Pharmacokinetic interaction of abacavir (1592U89) and ethanol in human immunodeficiency virus-infected adults - Wikidata - wikimedia - TriplyDB

Pharmacokinetic interaction of abacavir (1592U89) and ethanol in human immunodeficiency virus-infected adults

Pharmacokinetic interaction of abacavir (1592U89) and ethanol in human immunodeficiency virus-infected adults

http://www.wikidata.org/entity/Q33979817

about

Abacavir pharmacogenetics--from initial reports to standard of care Abacavir/lamivudine combination in the treatment of HIV: a review.PharmGKB summary: abacavir pathway Multiple-dose pharmacokinetics and pharmacodynamics of abacavir alone and in combination with zidovudine in human immunodeficiency virus-infected adults.The effects of alcohol on the pharmacokinetics and pharmacodynamics of the selective mu-opioid receptor antagonist GSK1521498 in healthy subjects Interactions between recreational drugs and antiretroviral agents.Abacavir/lamivudine fixed-dose combination antiretroviral therapy for the treatment of HIV.Weight related differences in the pharmacokinetics of abacavir in HIV-infected patients.Drug interactions in the management of HIV infection.Alterations in cellular pharmacokinetics and pharmacodynamics of elvitegravir in response to ethanol exposure in HIV-1 infected monocytic (U1) cells.Alcohol use disorders among people living with HIV/AIDS in Southern Brazil: prevalence, risk factors and biological markers outcomes Abacavir sulfate/lamivudine/zidovudine fixed combination in the treatment of HIV infection.Drug interactions involving ethanol and alcoholic beverages.Drug interactions in the management of HIV infection: an update.Alcohol's role in HIV transmission and disease progression.Pharmacokinetic and pharmacodynamic drug interactions with ethanol (alcohol).A Review of the Toxicity of HIV Medications II: Interactions with Drugs and Complementary and Alternative Medicine Products Predicting Clearance Mechanism in Drug Discovery: Extended Clearance Classification System (ECCS).Antiretroviral therapy in HIV-infected adolescents: clinical and pharmacologic challenges.Abacavir-induced fulminant hepatic failure in a HIV/HCV co-infected patient.HIV-1 Reverse Transcriptase Still Remains a New Drug Target: Structure, Function, Classical Inhibitors, and New Inhibitors with Innovative Mechanisms of Actions.Can fomepizole be substituted by abacavir in the treatment of methanol poisoning?Antiretroviral Therapy and Alcohol Interactions: X-raying Testicular and Seminal Parameters Under the HAART Era.

P2860

Q27008841-DF408DEE-C7D6-467D-A3EA-F07902A9AFCD Q33715435-D4769D12-A540-4243-9752-22A5015CD0B9 Q33819062-14FB5D91-E149-4B23-878B-C62B9C8C0E0C Q33980172-A484E16A-A2CE-4762-AACD-EBEE73D84C23 Q34806003-5EB2CAE9-A4E7-4199-A3BD-E629683040CB Q34874414-D0338B94-4D36-439D-A0FE-8E55932C5FB0 Q35233168-4954A58E-261E-49CF-B550-313137295568 Q35826691-65538847-FD88-4F6E-81A2-56DFCF3CE249 Q36066083-EA5ECA6B-2B8C-4056-ADD5-7FB98E11FFB7 Q36288425-960FF07F-D780-4AEE-AD53-C850EA9887E1 Q36343740-CB7E5BC0-9D5B-4420-959F-E181C0A0773C Q36739802-3EF41D4C-A310-4E86-B604-97DACDE30549 Q36960553-A3C0BC50-BD8F-486C-AD69-A475B3537547 Q37000733-0946F70D-2F35-4A6E-A3FA-C6553B948173 Q37386658-94269050-31A8-42BF-BF74-9822FFB3A21C Q38255420-4DD3AA24-220C-4CB7-BA2C-DC999BF5B5C8 Q38513275-F63CEACD-CEE9-4EF8-83A2-1434651FB6D4 Q38855314-7A7FD364-2F1B-4FBE-AC0B-4E6C99DB1A43 Q38910835-0DD52713-2974-49F0-8EA7-830579DFF32D Q40869976-0565D051-2BF1-40A3-9B5C-CE023DE576B6 Q41879018-0B1A9FC8-BACA-4F55-94AA-9A1286C0D783 Q43072820-23B9DCE2-8700-4C3F-9695-758E67B178E8 Q46496164-3F15CC30-AB7C-47A1-A400-235D79EC6554

P2860

Pharmacokinetic interaction of abacavir (1592U89) and ethanol in human immunodeficiency virus-infected adults

http://www.wikidata.org/entity/Q33979817

description

2000 nî lūn-bûn

@nan

2000 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Pharmacokinetic interaction of ...... ficiency virus-infected adults

@ast

Pharmacokinetic interaction of ...... ficiency virus-infected adults

@en

type

label

Pharmacokinetic interaction of ...... ficiency virus-infected adults

@ast

Pharmacokinetic interaction of ...... ficiency virus-infected adults

@en

prefLabel

Pharmacokinetic interaction of ...... ficiency virus-infected adults

@ast

Pharmacokinetic interaction of ...... ficiency virus-infected adults

@en

P1433

Q33979817-449389B1-A642-4E60-BFE0-FEB62D999DAF

P1476

Q33979817-DF19BECB-4822-4DD2-AC1D-C9C8EA08D61B

P2093

Q33979817-00A8D451-E69A-4BF8-AC32-5EF9A5DCF23F

Q33979817-895CEF21-CA71-453B-9404-0D688D428AAF

Q33979817-96650996-A726-43F5-9FCB-03E01BE7CBC2

Q33979817-B16E681B-EA76-4CBC-A8CC-39AFC141CF09

Q33979817-BCE683A9-06EB-4D53-96D8-EA82BA84257A

P2860

Q33979817-31F9632C-CA1C-4805-A7AE-2129A301F0F2

Q33979817-36294C26-84A7-43C2-8167-65CD4AD0462A

Q33979817-7229EAB7-6E70-4925-A928-5A5BC1FAFE89

Q33979817-81F1E27F-35E6-43B6-A154-4064429B6333

Q33979817-8D508EC0-33B9-4CE8-914E-F3AB39F4F442

Q33979817-90FB35F4-A283-4209-B2B1-803D238060BE

Q33979817-A80A84E2-E10B-4C66-8010-59821172687D

Q33979817-B2FFBEE1-071D-44EF-8AC5-0EF87CA8DDB6

Q33979817-D10B4EE0-FA58-4A8F-BFF5-12799E249E18

Q33979817-DD10D568-656B-4256-B7B8-F7C1D6AD39D8

P304

Q33979817-F815A2E5-FF3C-494C-A42F-5495DE757886

P31

Q33979817-9AE9E0BF-547B-4368-9633-985BEEAFD564

P356

Q33979817-2B3CC2ED-6802-4D83-974F-5507A33BA5AD

P407

Q33979817-AB5F74BA-8852-4D55-BAEC-7A1C556F3222

P433

Q33979817-B3C667DC-C32B-4221-A1D3-813C70CAC32A

P478

Q33979817-6C10B103-9401-4370-B66E-AE2CA594BD68

P577

Q33979817-9FEF0AF3-5A14-4CD7-95C2-64FEB90EDB90

P5875

Q33979817-D8E15C49-A6D5-4E52-8EE7-BA879FCF35B8

P698

Q33979817-03FF7203-840A-4739-B0BD-A8754C9B13BD

P932

Q33979817-6F1AB9E3-9B49-4A08-9F31-C0E4A1CBE903

P356

AAC.44.6.1686-1690.2000

P1433

Antimicrobial Agents and Chemotherapy

P1476

Pharmacokinetic interaction of ...... ficiency virus-infected adults

@en

P2093

C P Stevens

http://www.w3.org/2001/XMLSchema#string

D S Stein

http://www.w3.org/2001/XMLSchema#string

G E Chittick

http://www.w3.org/2001/XMLSchema#string

J A McDowell

http://www.w3.org/2001/XMLSchema#string

K D Edwards

http://www.w3.org/2001/XMLSchema#string

P2860

1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults

1592U89, a novel carbocyclic nucleoside analog with potent, selective anti-human immunodeficiency virus activity

Safety and pharmacokinetics of abacavir (1592U89) following oral administration of escalating single doses in human immunodeficiency virus type 1-infected adults

Single-dose pharmacokinetics and safety of abacavir (1592U89), zidovudine, and lamivudine administered alone and in combination in adults with human immunodeficiency virus infection

High blood alcohol levels in women. The role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism.

A review of the pharmacokinetics and pharmacodynamics of disulfiram and its metabolites.

A dose-ranging study to evaluate the safety and efficacy of abacavir alone or in combination with zidovudine and lamivudine in antiretroviral treatment-naive subjects.

Increased human immunodeficiency virus type 1 replication in human peripheral blood mononuclear cells induced by ethanol: potential immunopathogenic mechanisms.

Pharmacokinetic interactions of alcohol and acetylsalicylic acid.

Absence of effect of ranitidine on blood alcohol concentrations when taken morning, midday, or evening with or without food.

P304

1686-1690

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.44.6.1686-1690.2000

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

44

http://www.w3.org/2001/XMLSchema#string

P577

2000-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12499716

http://www.w3.org/2001/XMLSchema#string

P698

10817729

http://www.w3.org/2001/XMLSchema#string

P932

89933

http://www.w3.org/2001/XMLSchema#string